Bone marrow mesenchymal stem cells improve bone cancer pain by inhibiting p38MAPK phosphorylation and microglia activation. [PDF]
Kan H+8 more
europepmc +1 more source
''Mitigating cancer pain: What else matters?"-A qualitative study into the needs and concerns of cancer patients in Sri Lanka. [PDF]
Edirisinghe NP+3 more
europepmc +1 more source
The role of cancer cell-released extracellular vesicles: have we become closer to cancer pain treatment? [PDF]
Khasabova IA, Khasabov SG, Simone DA.
europepmc +1 more source
Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives
ABSTRACT Myelofibrosis (MF) is a myeloproliferative neoplasm that is accompanied by driver JAK2, CALR, or MPL mutations in more than 90% of cases, leading to constitutive activation of the JAK–STAT pathway. MF is a multifaceted disease characterized by trilineage myeloid proliferation with prominent megakaryocyte atypia and bone marrow fibrosis, as ...
Giuseppe G. Loscocco, Paola Guglielmelli
wiley +1 more source
Hyperthermia combined with opioid therapy: Enhancing cancer pain management and reducing surgical stress in gastrointestinal cancer patients. [PDF]
Wang Y+6 more
europepmc +1 more source
Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain
Clara C. Faura+4 more
openalex +1 more source
Topics of Interest in Women With Myeloproliferative Neoplasms
Women with MPN: life‐cycle phases, specific risks, and influencing factors. ABSTRACT Overview Sex and gender have emerged as central modifiers of disease biology, phenotype, and clinical outcomes in myeloproliferative neoplasms (MPNs). This review will uniquely highlight issues affecting women with MPN and articulate their relevant determinants ...
Natasha Szuber+2 more
wiley +1 more source